Yep.... partner the PS platform with a sense of urgency.
Calling the platform a failure and suggesting an end to clinical development, might not be the the best approach to partner negotiations. If they believe different than what they say, it does not help shareholders in any potential deal. Their sense of urgency may only be an effort to get votes. Hopefully they do not believe everything they say.
News 
Market Data 
Discover 
AI
